West Pharmaceutical Services, I – Consensus Indicates Potential 26.4% Upside

Broker Ratings
[shareaholic app="share_buttons" id_name="post_below_content"]

West Pharmaceutical Services, I with ticker code (WST) have now 5 analysts covering the stock. The analyst consensus points to a rating of ‘Buy’. The target price ranges between 410 and 341 calculating the mean target price we have 386.2. Now with the previous closing price of 305.46 this would indicate that there is a potential upside of 26.4%. The 50 day MA is 353.97 and the 200 day moving average is 403.3. The market cap for the company is $23,794m. Visit the company website at: https://www.westpharma.com

The potential market cap would be $30,083m based on the market concensus.

West Pharmaceutical Services designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

Twitter
LinkedIn
Facebook
Email
Reddit
Telegram
WhatsApp
Pocket
Find more news, interviews, share price & company profile here for:

      Search

      Search